Literature DB >> 1314176

Susceptibility of anaerobic bacteria to PD 131628.

C E Nord1, A Hagelbäck.   

Abstract

The in vitro activity of PD 131628 against anaerobic cocci, Propionibacterium acnes, Clostridium perfringens, Clostridium difficile, Bacteroides fragilis, Bacteroides spp. and fusobacteria was determined by the agar dilution method. This activity was compared with that of ciprofloxacin, piperacillin, cefoxitin, imipenem, clindamycin, metronidazole and chloramphenicol. PD 131628, imipenem, clindamycin, metronidazole and chloramphenicol were the most active agents tested.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1314176     DOI： 10.1007/bf01971277

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  2 in total

1.  Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis.

Authors:  K Dornbusch; C E Nord; B Olsson-Liljeqvist
Journal:  Scand J Infect Dis Suppl       Date:  1979

2.  In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine anti-infective agent.

Authors:  M A Cohen; M D Huband; G B Mailloux; S L Yoder; G E Roland; J M Domagala; C L Heifetz
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191
  2 in total
  1 in total

Review 1.  Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections.

Authors:  J A Balfour; H M Bryson; R N Brogden
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.